We are live on ! Find out more
VTAK icon

Catheter Precision

10 hedge funds and large institutions have $202K invested in Catheter Precision in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

25% more funds holding

Funds holding: 810 (+2)

0.07% more ownership

Funds ownership: 0.32%0.39% (+0.07%)

7% less capital invested

Capital invested by funds: $217K → $202K (-$14.4K)

Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

VTAK Hedge Fund Activity: Q1 2025 in Review

10 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q1 2025, worth a combined $202K — down 6.6% from $217K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new VTAK positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Armistice Capital, adding an estimated $48.5K. The largest seller was Warberg Asset Management, cutting an estimated $51.8K.

  • 10 institutional investors held Catheter Precision (VTAK) as of Q1 2025, up from 8 in Q4 2024.
  • Funds reported $202K of Catheter Precision stock for Q1 2025, down 6.6% quarter-over-quarter.
  • 3 funds opened new Catheter Precision positions in Q1 2025 and 1 closed out, a net change of +2 holders.
  • The largest Catheter Precision buyer in Q1 2025 was Armistice Capital, an estimated $48.5K added.
  • The largest Catheter Precision seller in Q1 2025 was Warberg Asset Management, an estimated $51.8K sold.

Based on aggregated 13F filings for Q1 2025.